ATXS logo

Astria Therapeutics, Inc. Common Stock


ATXS: Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.


Show ATXS Financials

Consumer Interest
SEC Filings

Recent trades of ATXS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by ATXS's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ATXS in WallStreetBets Daily Discussion


Recent insights relating to ATXS

CNBC Recommendations

Recent picks made for ATXS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ATXS

Corporate Flights

Flights by private jets registered to ATXS